Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.3633
S.3633: Transparency in Drug Labeling Act
About This Bill
- This bill was introduced in the 110th Congress
- This bill is primarily about health
- Introduced Sept. 26, 2008
- Latest Major Action Sept. 26, 2008
Bill Sponsor
Bill Summary
Transparency in Drug Labeling Act - Amends the Federal Food, Drug, and Cosmetic Act to deem a drug to be misbranded unless the labeling of such drug lists the identity of the country of manufacture of each active ingredient and each inactive ingredient of the drug, listed in descending order based on the percentage of the number of such ingredients in the final dosage form manufactured in such countries.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Sponsor introductory remarks on measure.
|
|
|
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
|
| Sept. 26, 2008 |
Introduced in the Senate by Sherrod Brown (D-Ohio) |